Lupin gains on entering into strategic partnership with Merck Serono

16 Sep 2014 Evaluate

Lupin is currently trading at Rs 1416.50, up by 1.70 points or 0.12% from its previous closing of Rs. 1414.80 on the BSE.

The scrip opened at Rs. 1434.90 and has touched a high and low of Rs. 1442.30 and Rs. 1367.95 respectively. So far 97077 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1422.00 on 15-Sep-2014 and a 52 week low of Rs. 833.55 on 18-Sep-2013.

Last one week high and low of the scrip stood at Rs. 1422.00 and Rs. 1307.25 respectively. The current market cap of the company is Rs. 61977.84 crore.

The promoters holding in the company stood at 46.73% while Institutions and Non-Institutions held 42.72% and 10.55% respectively.

Lupin has entered into a long term strategic partnership with Merck Serono, the Biopharmaceutical division of Merck. Lupin will support Merck Serono in the implementation of the company’s General Medicines portfolio expansion initiative in emerging markets thus addressing local needs for affordable, high-quality medicines. The agreement builds on an established working relationship between the two companies, and could add up to 20 new products to the current portfolio. The first launches are expected in 2016.

Through this partnership, Merck Serono will expand its overall portfolio in core therapeutic areas of Merck Serono’s General Medicine & Endocrinology franchise in selected countries in Latin America, Asia, Central Eastern Europe, and Africa.

The partnership covers major markets such as Brazil, Mexico, Indonesia, Philippines alongside several countries in Africa and Central Eastern Europe as well as other countries in emerging markets, focusing on cardiovascular and diabetes diseases. In Africa, medicines will also be supplied for additional therapeutic areas, reflecting local healthcare needs such as availability of antibiotics.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations and APIs globally.

Lupin Share Price

2176.25 -18.75 (-0.85%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×